Do you want to buy antibiotics online without prescription? http://buyantibiotics24h.com/ - This is pharmacy online for you!

Savvas papacostas cv


Current Positions:
Senior Consultant Neurologist,
Head of Clinic B:
Epilepsy Evaluation and Treatment Center,
Memory Disorders Center,
Clinical Neurophysiology,
The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
Adjunct Associate Professor of Neurology (Division of Epilepsy), University of
Rochester Medical Center, Rochester, New York, USA
Visiting Associate Professor of Neurophysiology, University of Cyprus, Nicosia,
Cyprus
WORK ADDRESS
The Cyprus Institute of Neurology and Genetics Fax. No. (357) 22392786
e-mail: savvas@cing.ac.cy
Savvas_Papacostas@urmc.rochester.edu
EDUCATION
1982-1986 Medical Degree
1980-1982 Master’s Degree Case Western Reserve University POSTGRADUATE TRAINING

1992-1993
Post-Doctoral Fellow in Clinical Neurophysiology and Epilepsy, and Assistant in Neurology, Columbia-Presbyterian Medical Center, Columbia University, New York, N.Y., USA Combined Residency in Neurology and Psychiatry at the University of Rochester Medical Center, Strong Memorial Hospital, Rochester, New York, USA as follows: Chief Resident and Instructor in Neurology Medical Intern, Cafaro Memorial Hospital, and St. Elizabeth's Hospital and Medical Center, Youngstown, Ohio, USA
WORK EXPERIENCE

1/1994-present
Senior Consultant Neurologist, Section of Behavioral Neurology and Epilepsy Director, Neurology Clinic B and Department of Clinical Neurophysiology The Cyprus Institute of Neurology and Genetics Adjunct Associate Professor, Department of Neurology Officer of the Day on Contract Basis at the VA Medical Center Rochester Psychiatric Center, Rochester, N.Y., USA
ACADEMIC ACTIVITIES

TEACHING EXPERIENCE

1988-1992
Teaching medical students on the Psychiatry and Neurology Wards University of Rochester, Rochester, New York Teaching Psychiatry Residents on Neurological issues University of Rochester, Rochester, New York Teaching Neurology Residents on Clinical Neurophysiology Columbia University, New York, New York Teaching Brain Anatomy and Physiology to Graduate students, Intercollege University, Nicosia, Cyprus 2001 -2006 Teaching Brain Anatomy and Physiology to Graduate students, University of Cyprus, Nicosia, Cyprus 2003-2006 Teaching Psychopathology to Graduate Clinical Psychology students Intercollege University, Nicosia, Cyprus Visiting Assistant Professor, University of Cyprus Visiting Associate Professor, University of Cyprus
GRADUATE STUDENT SUPERVISION

Panayides, Socrates, M.Sc. Thesis: Translation into Greek, Validation, and
Development of the Quality of Life in Epilepsy Inventory, QOLIE-89
1998-1999
Papathanasiou, Eleftherios, Ph.D. Dissertation: Vestibular Evoked Potentials
2001-2004
Papastavrou, Evridiki, Ph.D. Research project: Stress impact on carers of patients
with Alzheimer’s disease. 2005
Themistocleous Demetra, M.A. Thesis: Quality of Life and Working Memory in
Patients with Temporal Lobe Epilepsy. 2007-2008
Nikou, Maria, M.A. Thesis: Quality of Life and Working memory in Patients with
Temporal Lobe Epilepsy. 2007-2008
Anastasiou, Irena, M.A. Thesis: Translation and Validation into Greek of the
Epilepsy Foundation Concerns Index and Co-administration with Beck’s
Depression Scale and Anxiety Measurement Scale to Patients with Epilepsy. 2008-
2009
OTHER
Member of the Technological University of Cyprus Advisory Committee for the
creation of the School for Health Sciences
Guideline Reviewer for the American Academy of Neurology Practice Parameters
SCIENTIFIC JOURNAL PEER REVIEWS

Epilepsia
The Journal of International Angiology
Neuroscience Letters
The Journal of the Neurological Sciences
Journal of Neurology, Neurosurgery and Psychiatry
Neuroepidemiology
Epileptic Disorders
RESEARCH PROPOSAL EVALUATIONS
European Science Foundation (EU)

PROFESSIONAL ACCREDITATION, ACTIVITIES AND AFFILIATIONS

Certified in Neurology by the American Board of Neurology and Psychiatry. Cert.
No. 38671. Year of certification, 1993
Diplomate of the National Board of Medical Examiners, USA
Licensed Physician by the State of New York (Licence No.170719-1), USA
Licensed Physician by the Republic of Cyprus (Licence N.2265)
Certified European Epileptologist by the European Epilepsy Academy
Certified Trainer in Epileptology by the European Epilepsy Academy
Active Member, American Academy of Neurology (AAN) 1994 - present
Member, AAN Section on Behavioural Neurology National Contact Point (Cyprus) for the Surveillance of Creutzfeldt-Jakob disease, in the European Union Member, International League Against Epilepsy Faculty of One Thousand Corresponding Member, American Epilepsy Society Founding Member and past member of the Executive Committee, Cyprus Academy of Neurology Founding Member and Current President, Cyprus Epilepsy Society, a Chapter of the ILAE Member European Epilepsy Academy (EUREPA) and Designated Epileptology Trainer Active Member, European Neurological Society (ENS) Member, ENS Subcommittee on Epilepsy and Sleep Disorders Member of the European Federation of Neurological Societies Scientist Panel of
Epilepsy
Member, Editorial Board, JAMA, Neurology & Psychiatry, Middle East
Member, Editorial Board, Archives of Neurology, Middle East
Scientific Advisor, Organisation for the Support of Alzheimer’s Patients
Scientific Advisor, Cyprus Parkinson’s Disease Organisation
Member, Cyprus Institute of Neurology & Genetics Scientific Council
RESEARCH

1981
Field work in the village of Platt, Northern Greece, on the epidemiology of Hepatitis B Utility assessment of geriatric patients on a geriatric ward in Edinburgh, Scotland Prevalence and Risk Factors of Postictal Psychosis in an inpatient epilepsy population. Clinical and Electrographic correlates. Columbia University, New York, USA Long-term follow-up of patients with psychogenic seizures. Columbia University, New York, USA Felbamate study participant. Antiepileptic partial epilepsy. Columbia University, New York, USA Comparison of normal Cypriot population to established standard parameters of normal values in evoked potentials Significance of mid-frontal to occipital dissociation of p100 1995 Open trials of Lamotrigine as add-on therapy in children aged Apolipoprotein E determination in Cypriot patients with Alzheimer’s Dementia and comparison with normal population European Consortium to establish a Genetic Basis of Epilepsy Gabapentin as Add-on Treatment in partial-onset resistant Topiramate as Add-on Treatment in Partial-Onset Resistant Epilepsy The Effect of Apolipoprotein E and Presenilin-1 on Late Onset Alzheimer’s Disease in Cyprus A Double-Blind, Randomised, Dose Comparison Study of AVONEX® (Interferon Beta-1a) in Subjects with Multiple Sclerosis. Principal Investigator for Cyprus Gulf and Middle East Study on Quality of life in People with Epilepsy. Principal Investigator for Cyprus -Genetic Analysis of Epilepsy Families -Evaluation of Neurogenic Vestibular Evoked Potentials in MS -Levetiracetam as add-on therapy in patients with intractable epilepsy -Age of onset, APOE status, education and family history in patients with Alzheimer’s disease -Impact on carers of people with Alzheimer’s Disease -Gallantamine in the treatment of Alzheimer’s disease patients -Evaluation of Neurogenic Vestibular Evoked Potentials -Epidemiology of Alzheimer’s Disease in Cyprus -Stress Impact on carers of Alzheimer’s Disease -Disssociation of mid-frontal from occipital positivity on VERs -EURO-CJD Epidemiological Surveillance of Transmissible Spongiform Encephalopathies in Europe FP-6/FP-7 funded -Investigation on the action of different medication classes on the reactivation of fetal hemoglobin -European Consortium on the genetic analysis of photosensitivity and visual sensitive epilepsies 2006 -Neurophysiological Correlates of developing Intelligence -Brain Activity correlates of developing intelligence in epileptic Children -Correlation of Psychopathology and Sleep disorders -Comparison of Psychogenic Seizure patients with matched Epileptic controls -Working memory and quality of life in patients with epilepsy -Translation, Validation and Application of the British Epilepsy Foundation Concerns Index to Cypriot epileptic -Pan-European Surveillance of Sudden Unexpected death in Epilepsy during Video-EEG Monitoring (MORTEMUS study) -The Neurocognitive Study of Aging -Safety and Efficacy of Esclicarbazepine as Add-on Therapy in Pharmacoresistant Partial-onset Epileptic Seizures: A Double-Blind, Randomized, Multi-Center Clinical trial -Applied Neuroscience and Neurobehavioral Research Center. A three year infrastructure award financed by the
HONORS AND AWARDS

Dean's List in Undergraduate College
Who's Who Among Students in American Colleges and Universities,
1978-1979
M.A. Degree Summa Cum Laude
Edinburgh Geriatric Tutorial Award, 1986
Special Mention was given by the “Hippocrates” Medical Association on Nicosia –
Kyrenia for the presentation: Papathanasiou ES, Kyriakides T, Iliopoulos I, Petsa
M, Kleopa KA, Piperidou C, Pantzaris M, Papacostas SS. “Vestibular symptoms
and signs are correlated with abnormal neurogenic vestibular evoked potentials
in patients with multiple sclerosis”. 18th Annual Medical Conference, 9-10 April,
2005, Nicosia, Cyprus
Fellow of the American Academy of Neurology, Elected in February 2011.

PUBLICATIONS


Peer-Reviewed Articles

Grollman EN, Papacostas SS: "Acquired Dementia with Retinitis Pigmentosa",
Journal of Geriatric Psychiatry and Neurology, 7(1):18-22, 1994
Walczak TS, Papacostas SS, Williams DT, Scheuer ML, Lebowitz N and
Notarfrancesco A: "Outcome After Diagnosis of Psychogenic Nonepileptic
Seizures", Epilepsia 36(11):1131-1137, 1995
Papathanasiou ES, Galganski-Cleanthous M, Pattichis C, Middleton L, Papacostas
S. “Evoked Potentials of the Cyprus Institute of Neurology & Genetics. I: Normal
Parameters for Brainstem Auditory Evoked Potentials”. Cyprus Medical Journal 14
(3 & 4):52-55, 1996.
Papathanasiou E, Galganski-Cleanthous M, Middleton LM, Pattichis C, and
Papacostas S: “Evoked Potentials at the Cyprus Institute of Neurology and
Genetics II: Normal Parameters for Visual Evoked Potentials (VEPs)”, Cyprus
Medical Journal (In Press).
Papathanasiou ES, Cleanthous MEG, Papacostas SS, Discussion: Using
Statistics to Determine the Tolerance Limits of Normal Values in Evoked Potential
Testing”, American Journal of Eletroneurodiagnostic Technology 38:33-42 1998
Papathanasiou E, Panayiotou P, Galganski-Cleanthous M, Middleton L, Stylianidou
G, Koukkoulli R, and Papacostas SS, “Ambulatory Electroencephalography is
Useful in Differentiating Seizures from other Behavioural Changes in Children”,
Cyprus Medical Journal 16 (1&2): 14-16, 1998.
Papacostas SS and Papathanasiou E, “Reversible Phenytoin Induced
Dyskinesias”, Cyprus Medical Journal 16 (1&2): 34-36, 1998.
Papacostas SS, “Subclinical Electrographic Rhythmic Discharge in Adults: Report
of a Case and Review of the Literature. Cyprus Medical Journal 17 (3&4):14-17,
2000
Papacostas SS, Hadjivassilis V. “Kleine-Levin Syndrome: Report of a Case and
Review of the Literature”. European Psychiatry 15:231-5, 2000
Papacostas SS. “Oxcarbazepine versus Carbamazepine Treatment and Induction
of Serum Lipid Abnormalities: Report of A Case.” Journal of Child Neurology
2000;15(2):138-40
Papacostas S. Alzheimer’s Disease: “Therapeutic Developments”. Cyprus
Medical Journal 17(1&2):16-18, 2000
Papathanasiou E, Zamba E, Papacostas S. “Radial Nerve F-Waves”. Journal of
Clinical Neurophysiology 2001(112); 145-152
Papathanasiou E, Zamba E, Papacostas S. “Normative Values for High Voltage
Stimulation across the Brachial Plexus” Elecrtomyography and Clinical
Neurophysiology, 42:151-157, 2002
Wijdicks, Eelco; Gustavo Saposnik; Marnia Davtian; Jean Marquez; Paulo
Bittencourt; Jorge Alegria; Pablo Lorenzana-Pombo; Enrique Hernandez; Calixto
Machado; Savvas Papacostas; Adriana Slobodova; Tomas Alarcon; Mohamed El-
Tamawy; Francisco Ivan Ordonez; Ain-Elmar Kaasik; Walter Haupt; Ben Edoo;
Jhon Logothetis; Rodolfo Gebhart; Ian Morales; Kollár Tibor; Kurupath
Radhakrishnan; Kahnar Wiriadisastra; Mark Keegan; John Hall; Hiroshi Takeshita;
Ashraf Kurdi; Sejin Lee; Chong-Tin Tan; Norbert Vella; Pratap Chand; Zaheer
Aslam; Telmo Aquino; Rene Punsalan; Ahmad Hamad; Tak-Sun Tse; Mihvea
Chiorean; Pvel Pilipenko, Valery Feigin; Imad Unin Kanaan, Zuheir Al-Kawi;
Jamshid Davantou; Peter Turcani; Jordi Peña-Casanova; Lars Forsgren; Sung-
Tsang Hsieh; Gaspar Kitange; Niphon Poungvarin; Kanter Ramcharan; M. ben
Hamida; Bursen Ince; Jon Dorman; Igor Vishvevsky; Carlos Chouza; Angelina
Faoro; Thong van Nguyen; Milorad Zikic. “Brain death worlwide: Accepted fact but
no global consensus in diagnostic criteria”. Neurology 58:20-25, 2002
M. Clanet, E.W. Radue, L. Kappos, H.P. Hartung, R. Hohlfeld, M. Sandberg-
Wollheim, M.F. Kooijmans-Coutinho, E.C. Tsao, A.W. Sandrock, W. Kristoferitsch,
Schrieber, Schlederer A, Seeldrayers, Piette B, S. Papacostas, K. Kyriallis, M
Pantzaris, B. Brochet, A. Gayou, M. Rouanet, F. Rouant, C. Confavreux, G. Riche,
S. Blanc, J. Achiti, C. Magnier, P. Aubertin C. Mekies, D. Brassat, C. Thalamas, C.
Vuilleman, A. Senard, G. Lau, P. Cesaro, F. Degos G. Defer, Treating S. Schaeffer
G. Edan, de Marco, V. Cahagne, S. Belliard, O. Lyon-Caen, B. Stankoff, C.
Lubetzki, I. Arnulf, P. Damier, J. Pelletier, D. Tamman, L. Suchet, A. Dalecky, L.
Rumbach, Treating Dr. Moulin, E. Berger E. Roullet, D. Pez, O. Heinzlef, P.
Lecanuet, P. Vermersch, A. Engles R. Dengler, F. Heidenreich, Examining Dr.
Lindert, Dr. Koehler, Dr. Windhagen, D. Steiner, R. Zschenderlein, J. Luenemann,
H. Gelderblom, N. Kassim, B. Storch-Hagenlocher, D. Koerner, D. Vogt-Schaden,
D. Stingle, D. Storch-Hagenlocher, M. Sailer, D. Matzke, R. Hohlfeld, D. Dose, C.
Weiler, K. Kunze, C. Heesen, P. Bamborschke, H. Petereit, D. Liu, Dr. Nolden, F.
Grunwald, D. Menck, D. Grupe, H.-P. Hartung, P. Rieckmann, D. Weilbach, D.
Flachenecker, D. Chan, D. Maurer, J. De Keyser, G. Zwanniken, D. Azordrager,
X. Montalban, D. Nos, O. Fernández, J.A. Tamayo, F. Romero, T. Arbizu, D.
Martínez-Yélamos, D. Martin, D. Casado, M. Sandberg-Wollheim, R. Ekberg. N.
Achalbedaschwili, D. Schött, C. Lienert, E. Luthringer, D. Bates, M. Westwood,
M.J. Campbell, D. Burrows, R. Capildeo, D. Abbas, D. Riaz A. Compston, I.
Bjornson, C.P. Hawkins, S. Wetherby, S. Ellis, S. Hawkins, M. Duddy D.L.
McLellan, S. Wroe, K. Powell, C.A. Young, Co-investigator Dr. Lecky, P.
Rieckmann, C. Polman, J. Kesselring, A. Thompson, H. Wekerle, J. Whitehead. “A
randomized, double-blind, dose-comparison study of weekly interferon {beta}-1a in
relapsing MS“ Neurology, 59: 1507, 2002
Papacostas S. “Photosensitivity during the Hypersomnic Phase in a Patient with
Kleine-Levin Syndrome. Report of a Case”, Journal of Child Neurology 18 (6):432-
433, 2003
Papacostas S. “Description and Organization of the Comprehensive Epilepsy
Monitoring Unit”, Cyprus Medical Journal 20 (1&2):42-44, 2003
Papathanasiou E, Zamba-Papanicolaou E, Pantziaris M, Kyriakides T, Papacostas
S, Myrianthopoulou P, Pattichis C, Iliopoulos Y, Piperidou C. “Click Evoked
Neurogenic Vestibular Potentials (NVESTEPs): A Method of Assessing the
Function
Neurophysiology 43: 399-408, 2003
Papathanasiou ES, Myrianthopoulou P, Papacostas S. “Knitting artifact on
EEG”. Neurological Pictures: Journal of Neurology, Neurosurgery and Psychiatry
74:1501, 2003
Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Kooijmans-
Coutinho M, Clanet M, Radue EW, Papacostas S, Berrry I, Differ G, Lyon-Caen
O, Roulett E, Rumbach L, Weiller C, Bamborschke S, Hartung HP, Riekmann P,
Sandberg-Wollheim M, Ekberg R, Bates D, Hawkins C, Kappos L,. “Atrophy Is
Detectable Within a 3-Month Period in Untreated Patients With Active Relapsing
Remitting Multiple Sclerosis” Archives of Neurology, 60:1736–1739, 2003
Papathanasiou E, Zamba-Papanicolaou E, Pantzaris M, Kleopa K, Kyriakides T,
Papacostas S, Pattichis C, Iliopoulos I, Piperidou C. “Neurogenic Nestibular
Evoked Potentials Using a Pip Auditory Stimulus”. Electromyography and Clinical
Neurophysiology 44: 167-173, 2004
Clanet, M, Kappos, L, Hartung, HP, Hohlfeld, R. M. Sandberg-Wollheim, M.F.
Kooijmans-Coutinho, E.C. Tsao, A.W. Sandrock, W. Kristoferitsch, Schrieber,
Schlederer A, Seeldrayers, Piette B, S. Papacostas, K. Kyriallis, M Pantzaris, B.
Brochet, A. Gayou, M. Rouanet, F. Rouant, C. Confavreux, G. Riche, S. Blanc, J.
Achiti, C. Magnier, P. Aubertin C. Mekies, D. Brassat, C. Thalamas, C. Vuilleman,
A. Senard, G. Lau, P. Cesaro, F. Degos G. Defer, Treating S. Schaeffer G. Edan,
de Marco, V. Cahagne, S. Belliard, O. Lyon-Caen, B. Stankoff, C. Lubetzki, I.
Arnulf, P. Damier, J. Pelletier, D. Tamman, L. Suchet, A. Dalecky, L. Rumbach,
Treating Dr. Moulin, E. Berger E. Roullet, D. Pez, O. Heinzlef, P. Lecanuet, P.
Vermersch, A. Engles R. Dengler, F. Heidenreich, Examining Dr. Lindert, Dr.
Koehler, Dr. Windhagen, D. Steiner, R. Zschenderlein, J. Luenemann, H.
Gelderblom, N. Kassim, B. Storch-Hagenlocher, D. Koerner, D. Vogt-Schaden, D.
Stingle, D. Storch-Hagenlocher, M. Sailer, D. Matzke, R. Hohlfeld, D. Dose, C.
Weiler, K. Kunze, C. Heesen, P. Bamborschke, H. Petereit, D. Liu, Dr. Nolden, F.
Grunwald, D. Menck, D. Grupe, H.-P. Hartung, P. Rieckmann, D. Weilbach, D.
Flachenecker, D. Chan, D. Maurer, J. De Keyser, G. Zwanniken, D. Azordrager,
X. Montalban, D. Nos, O. Fernández, J.A. Tamayo, F. Romero, T. Arbizu, D.
Martínez-Yélamos, D. Martin, D. Casado, M. Sandberg-Wollheim, R. Ekberg. N.
Achalbedaschwili, D. Schött, C. Lienert, E. Luthringer, D. Bates, M. Westwood,
M.J. Campbell, D. Burrows, R. Capildeo, D. Abbas, D. Riaz A. Compston, I.
Bjornson, C.P. Hawkins, S. Wetherby, S. Ellis, S. Hawkins, M. Duddy D.L.
McLellan, S. Wroe, K. Powell, C.A. Young, Co-investigator Dr. Lecky, P.
Rieckmann, C. Polman, J. Kesselring, A. Thompson, H. Wekerle, J. Whitehead. “
Interferon -1a in relapsing multiple sclerosis: four-year extension of the European
IFN -1a Dose-Comparison Study”. Multiple Sclerosis 10(2);139-144, 2004.
Panayides S, Goldstein HL, Mouratoglou V, Papacostas S. “Patient-validated
Content of a Greek Version of the Quality of Life in Epilepsy Inventory (QOLIE-89)
Combined with Individualized Measures”. Epilepsy and Behavior 5(3): 367-379,
2004
Papathanasiou E, Pantzaris M, Zamba-Papanicolaou E, Kyriakides T, Kleopa K,
Iliopoulos I, Piperidou C, Papacostas S. “Neurogenic Vestibular Evoked Potentials
in the Diagnosis of Multiple Sclerosis” Electromyography and Clinical
Neurophysiology, 44: 313-317, 2004
Papacostas S, Petsa M, Myrianthopoulou P, Papathanasiou E. “The use of
Video-EEG monitoring in the detection of pseudoseizures”. Cyprus Medical
Journal, 21(3-4):11-13, 2004
Papathanasiou E, Loizides A, Panayiotou P, Papacostas S, Kleopa K. “Ulnar
Neuropathy at Guyon’s Canal: Electrophysiological and Surgical Findings”. J
Electromyography and Clinical Neurophysiology, 45:87-92, 2005
Baker GA, Jacoby A, Gorry J, Doughty J, Ellina V, and the SIGN Group
(Membership of the SIGN group: Adel Al Jishi, Hajir Sikaroodi, Sayed Jalal Ziaei,
Kurosh Gharagozli, Reza Khandaghi, Mohammad Hossein Harirchian, Shahriar
Nafissi, Manouchehr Ilkhani, Jamshid Lotfi, Mohammad Mehdi Zolfaghari, Majid
Ghafarpour, Mahmoud Motamedi, Mohammad Mehdi Etemadi, Hossein
Pakdaman, Alireza Nikseresht, Abdolrahman Najlerahim, Ballal Adibeig, Akbar
Soltanzahdeh, Mostafa Shirzadi, Babak Zamani, Anil Tusso, Asmahan Shubaily,
Pratap Chand, Subashini Prabhakar, Tag Eldin Sokrab, Richard McLachlan,
Manorama Devi, E.V. Joshy, Jihad Insashi, Chaker Khamis, Mounir Khoury, Naji
Riachi, Salim Atrouni, Kamel Ezzedine, Houssein Abed Ali, Abdul Rahman
Samra, Abbas Serhan, Hassan Abdallah, Raymond Chemaly, Rached Succari,
Hassan Eid, Shawkat Beaini, George Hanna, Bassem Yammout, Rosette
Jabour, Ali Mokdad, Mohammad Mikati, Abdellatif Wraikat, Fouad Ibrahim,
Adnan Al-Abdallat, Yacoub Al-Bahu, Fairouz Al Sayegh, Ahmad Khalifa, Imad
Saadeh, Nouha Toubal, Yaman Daboul, Savvas Papacostas, Andri Mallikidou,
and Socrates Panayides). “Quality of Life of People with Epilepsy in Iran, the
Gulf, and Near East”. Epilepsia, 46 (1):132-136, 2005
Papathanasiou ES, Piperidou C, Ilippoulos I, Malekidou A, Katelari-Theocharidou
E, Kyriakides T, Kleopa KA, Papacostas S. “Neurogenic vestibular evoked
potentials in three cases of vestibular system dysfunction”. Electromyography
and Clinical Neurophysiology, 45:39-45, 2005.
Papathanasiou ES, Piperidou C, Pantzaris M, Iliopoulos I, Petsa M, Kyriakides T,
Kleopa KA, Papacostas S. “Vestibular symptoms and signs are
correlated with abnormal neurogenic vestibular evoked potentials in patients
with multiple sclerosis”. Electromyography and Clinical Neurophysiology, 45:195-
201, 2005.
Papathanasiou ES, Piperidou C, Iliopoulos I, Myrianthopoulou P, Pilavakis P,
Papacostas S. "Brainstem auditory evoked responses that disappear during
sleep: A possible manifestation of a neurogenic vestibular evoked response".
Electromyography and Clinical Neurophysiology, 45:263-266, 2005
Hardmeier M, Wagenpfeil S, P. Freitag P, Fisher E, Rudick RA, Kooijmans M,
Clanet M, Radue EW, Kappos L, for the European IFNß-1a in Relapsing MS Dose
Comparison Trial Study Group: The MRI Subgroup consisted of the following
investigators: Seeldrayers P, Papacostas S, Berry I, Defer G, Lyon-Caen O,
Roullet E, Rumbach L, Brochet B, Confavreux C, Edan G, Pelletier J, Vermersch P,
Weiller C, Bamborschke P, Hartung HP, Rieckmann P, Dengler R, Heidenreich F,
Zschenderlein R, Storch-Hagenlocher B,Sailer M, De Keyser J, Sandberg-Wollheim
M, Ekberg R, Bates D, Hawkins CP, Campbell MJ, Hawkins S, Wroe S C.A. Young
CA. “Rate of brain atrophy in relapsing MS decreases during treatment with IFNß-
1a”. Neurology; 64:236-240, 2005
Papathanasiou ES, Theocharidou EK, Papacostas SS. “Parallel auditory
vestibular evoked neurogenic and myogenic potential results in a case of
peripheral vestibular dysfunction, showing that the former originates from the
vestibular system.” Electromyography and Clinical Neurophysiology, 46(2):105-
11, 2006
Papathanasiou ES, Papacostas SS, Charalambous M, Eracleous E, Thodi C,
Pantzaris M. “Vertigo and imbalance caused by a small lesion in the anterior
insula.” Electromyography and Clinical Neurophysiology, 46:185-192, 2006
Tofaris GK, Revesz T, Jacques TS, Papacostas S, Chataway J. “Adult-onset
Neurodegeneration with Brain Iron Accumulation and cortical α-synuclein and tau
pathology:a
2007;64:280-282.
Papacostas SS, Myrianthopoulou P, Papathanasiou ES. “Epileptic seizures
followed by nonepileptic manifestations: A Video-EEG diagnosis”.
Electromyography and Clinical Neurophysiology, 46:323-327, 2006
Papacostas SS, Myrianthopoulou P, Dietis A, Papathanasiou ES “Induction of
central-type sleep apnea by vagus nerve stimulation”. Electromyography and
Clinical Neurophysiology, 47:61-63, 2007
Papastavrou E, Kalokerinou-Anagnostopoulou A, Alevizopoulos G, Papacostas
S
, Tsangari H, Sourtzi P. “The validity and reliability of the Zarit burden interview
in Greek Cypriot carers of patients with dementia”. Nosileftiki (Nursing)
45(4):439-449, 2006
Papacostas S, Kkolou E, Papathanasiou ES.Levetiracetam in three cases of
progressive myoclonus epilepsy” Pharmacy World & Science, 29(3):164-6, 2007
Papastavrou E, Kalokerinou A, Papacostas SS, Tsangari H, Sourtzi P. “Caring
for a Relative with Dementia: Family Caregiver Burden”. Journal of Advanced
Nursing: 58(5):446-57, 2007.
Papacostas SS, Papathanasiou ES, Myrianthopoulou P, Stylianidou G.
“Tuberous Sclerosis Successfully Treated with Levetiracetam Monotherapy: 18
Months of Follow-up”. Pharmacy World & Science, 29(4): 350-352, 2007
Papathanasiou ES, Papacostas SS. “Letter to the Editor: Neurogenic Vestibular
Evoked Potentials in Multiple Sclerosis Patients”. Journal of Vestibular Research
17(4): 205, 2007.
Papathanasiou ES, Papacostas SS. “Flash electroretinography: Normative
values with surface skin electrodes and no pupil dilation using a standard
stimulation protocol”. Documenta Ophthalmologica, 116(1):61-73, 2008.
Papastavrou E, Kalokerinou Anagnostopoulou A, Alevizopoulos G, Papacostas
SS
, Kalakoutas Y, Sourtxim P. “Validation of the Zarit Burden Interview in Greek”.
Cyprus Medical Journal, 24(1-2): 31-39, 2008.
Papacostas S, Malikides A, Petsa M, Kyriakides T. “10-year mortality from
Creutzfeldt- Jakob disease in Cyprus”. WHO – Eastern Mediterranean
Health Journal, 14(3): 715-719, 2008.
Papastavrou E, Tsangari C, Kalokerinou A, Papacostas S, Sourtzi P.
“Assessment of the Memory and Behavior Problems of Patients with Dementia”.
Nursing Care and Research, 22:19-28, 2008.
Papathanasiou ES, Papacostas SS. “Letter to editor: Sleep Related Disorders
in Children with Vagal Nerve Stimulators”. Pediatric Neurology, 39(2):142, 2008.

Papastavrou E, Tsangari H, Kalokerinou A, Papacostas SS, Sourtzi P. “Gender
issues in caring for demented relatives”. Health Sciences Journal, 3(1):41-53,
2009.
Papathanasiou ES, Lemesiou A, Hadjiloizou S, Myrianthopoulou P, Pantzaris M,
Papacostas SS. “A New Neurogenic Vestibular Evoked Potential (N6) Recorded
with the Use of Air-Conducted Sound”. Otology and Neurotology.31(3):528-535,
2010.
Papathanasiou ES, Myrianthopoulou P, Pantzaris M, Kkolou E, Papacostas SS.
“Brainstem lesions may be important in the development of Epilepsy in Multiple
Sclerosis patients: An evoked potential study”. Clinical Neurophysiology,
121(12):2104-10, 2010.
Kyriakides T, Papacostas SS, Papanicolaou E, Bagdates E, Papathanasiou ES.
"Sleep hypoventilation syndrome and respiratory failure due to Multifocal Motor
Neuropathy with Conduction Block". In Press: Muscle and Nerve.
Papastavrou E, Tsangari H, Karayiannis G, Papacostas S, Efstathiou G, Sourtzi
P. “Caring and coping: The dementia caregivers”. In Press: Aging & Mental
Health.
Invited Reviews and Book Chapters
Papathanasiou ES, Piperidou C, Papacostas S. “Vestibular Evoked
Potentials”. Advances in Clinical Neurosciences, 14:283-289, 2004
Evridiki Papastavrou, Athina Kalokairinou, Panagiota Sourtzi, Savvas
Papacostas
, Haritini Tsangari. “The pilot results of the family burden
experienced by families with a member suffering from dementia: The health
inequalities perspective”. In: “The price of life: Welfare systems, Social nets and
economic growth
” Cidadania, Lisboa, Edicoes Colibri/ CIDEHUS/UE, 2007,
pp.201-220.
Miscellaneous
Papacostas S
"Culture, Disease, and Healing" in EXPLORATIONS, Ohio
University Press, Athens, Ohio 1986
Papacostas S “Migraine” Health For All Quarterly Publication of the Cyprus
Ministry of Health, Vol. 4(8): 35-36 Sept-Dec 1998
Papacostas S, Koukkoullis R. Lamotrigine as Add-On Therapy in Children with
Treatment-Resistant Epilepsy. British Med Journal (Middle East ) vol.7 119-21 Oct
2000.
Papacostas S. “Epidemiologic Surveillance of Transmissible Spongiform
Encephalopathies in Cyprus”. Biannual Epidemiologic Surveillance Report of the
Ministry of Health of Cyprus, Jan-June Vol. 3 p.7, 2005
Papacostas S. “Mortality in Cyprus from Creutzfeldt-Jacob Disease during 1995-
2004” ”. Biannual Epidemiologic Surveillance Report of the Ministry of Health of
Cyprus, Jan-June Vol. 6 p.1-2, 2008.
ORAL PRESENTATIONS
Grand Rounds

"Neuropsychiatry of Head Trauma" Grand Rounds, Department of Psychiatry,
University of Rochester, Strong Memorial Hospital, Rochester, New York, June
1987
"Evaluation and Treatment of Dementia", Cyprus Institute of Neurology and
Genetics, Nicosia, Cyprus, December 1991
“Review of New Anti-epileptic Drugs”, Democretian University of Thrace Medical
School, Alexandroupolis, Greece, May, 1997
“Vestibular Evoked Potentials”, Cyprus Institute of Neurology & Genetics, Nicosia,
Cyprus, June 2002
“Neurogenic Vestibular Evoked Potentials: Technique and Preliminary Findings in
Patients with Multiple Sclerosis”, Cyprus Institute of Neurology & Genetics, Nicosia,
Cyprus, April 2003
Invited Speaker
"Progress
Neuroscience Conference, June 1994, Thessaloniki, Greece
"Mechanisms of Action of New Antiepileptic Medications", First Beirut-Nicosia
Neuroscience Meeting, October 1994, Beirut, Lebanon
"Progress in Antiepileptic Pharmacotherapy", Second Eastern Mediterranean
Neuroscience Conference, November 1994, Cairo, Egypt

"Mechanisms of Action New Antiepileptic Medications", Second Thessaloniki-
Nicosia Neuroscience Conference, April 1995, Nicosia, Cyprus
"Lamotrigine as Add-On Therapy in Children Aged 2-12 with Treatment Resistant
Epilepsy", Third Thessaloniki-Nicosia Conference on Neuroscience, May 1996,
Thessaloniki, Greece
"Progress in Antiepileptic Pharmacotherapy and Report on Study using Lamotrigine
as Add-On Therapy in Children with Treatment Resistant Epilepsy", First
International Conference on Epilepsy of the Ukrainian League Against Epilepsy,
May 1996, Kiev, Ukraine

“Memory Dysfunction”. 2nd Meeting of the Pancyprian Organisation for the Support
of Alzheimer’s patients, 6/11/1999, Larnaca, Cyprus

“When is epilepsy deemed intractable? When do new proceed to surgery?” World
Hellenic Biomedical Congress, 11-14 October 2000, Athens, Greece.
“Relationship of Bovine Spongiform Encephalopathy with New Variant Creutzfeldt-
Jakob disease”. Sponsored by the Ministry of Health of Cyprus for Cypriot
Practising Physicians. 12 Dec 2000, Nicosia, Cyprus
“Molecular and Biochemical Markers of Alzheimer’s Disease”. Presented at the
First International Conference of Alzheimer’s Disease of the Middle East. 17-19
April 2001, Limassol, Cyprus
“Molecular diagnosis and Biological markers of Alzheimer’s Disease”. 2nd
Panhellenic Scientific Congress on Alzheimer’s disease and related disorders, 17-
20 Jan 2002, Thessaloniki, Greece

“Quality of Life in Epilepsy”. 1st Mediterranean Congress of Neurology, 25-28 Apr
2002, Limassol, Cyprus
“Dementia” Hippocrates Medical Association of Nicosia-Kyrenia Continuing
Education Program, 26th Feb 2004, Nicosia Cyprus
“Alzheimer’s Disease” Larnaca Medical Associstion Continuing Education Program, 22nd July 2004, Larnaca, Cyprus “Dealing with Epilepsy in School”. 4th Seminar for the Continuing Education of School Medical Services, 13-14 Oct 2004, Nicosia, Cyprus “Symptomatic Focal Epilepsy”. 1st Panhellenic Epilepsy Congress, 21-23 Oct 2005, Athens, Greece “cognitive Side Effects of Antiepileptic Drugs”. 1st Panhellenic Epilepsy Congress, 21-23 Oct 2005, Athens, Greece “Sudden Unexpected Death in Epilepsy”. 2nd Panhellenic Epilepsy Congress, 10-12 Nov 2006, Thessaloniki, Greece “Future Treatments for Alzheimer’s Disease”. Pancyprian Association for the Care of People with Alzheimer’s Disease. 21st September, 2007-09-24, Nicosia, Cyprus “Classification of epileptic seizures according to the proposed scheme of 2001”. Meeting od the Panhellenic & Cyprus epilepsy societies, 22nd September, 2007, Limassol, Cyprus. “Epilepsy and Dementia”. 3rd Panhellenic Epilepsy Congress, 9-11 November, 2007, Athens, Greece. “Presurgical Evaluation of Adults with Intractable Epilepsy”. Meeting of the Greek Society of Electroencephalography & Clinical Neurophysiology on Developments in Clinical Neurophysiology, 8-9 December, 2007, Nicosia, Cyprus. “Epilepsy. Etiology, Diagnosis and Therapy”. Hippocrates Medical Association of Nicosia-Kyrenia continuing education series, 31st January, 2008, Nicosia, Cyprus. “CJD in Cyprus”. European and Associated Countries Collaborative CJD Surveillance Group Meeting, 29-31 May 2008, Riga, Latvia. Cyprus Ministry of Health Post-Graduate Training Conference on Alzheimer’s disease. A). Pathogenesis and Diagnosis. B). Epidemiology. 2nd October, 2008, Nicosia, Cyprus. “Memory Dysfunction and Quality of Life in Patients with Chronic Epilepsy”. Delivered in Memeory of Dr. Goula Styliadidou, at the 4th Panhellenic Epilepsy Congress 14-16 November 2008, Alexandroupolis, Greece. “Differential Diagnosis of Dementia”. 7th Pancyprian Congress of the “Asklepios” Medical Society of Paphos, 13-14 December, 2008, Paphos, Cyprus. “Restless Legs Syndrome”. 7th Pancyprian Congress of the “Asklepios” Medical
Society of Paphos, 13-14 December, 2008, Paphos, Cyprus.
“The role of the Multidisciplinary Team in the Management of Alzheimer’s Disease
– Round Table” 6th Panhellenic Join Conference on Alzheimer's Disease and
Related Disorders. 20-23 February, 2009, Thessaloniki, Greece.
“Idiopathic Generalized Epilepsies with Myoclonic Seizures in the Phenotype” 5th
Panhellenic Epilepsy Congress 6-8 November, 2009, Chania, Crete, Greece.
“Neurological Causes of Fainting”. Larnaca Medical Association Conference on
“Neurology in Primary Care”, 27 February, 2010, Larnaca, Cyprus
“Dementia: Types, Pathophysiology, Investigation and Treatment”. 1st Geriatric
Conference of the Cyprus Association of General Physicians, 08 May, 2010,
Nicosia, Cyprus
“The Epidemiology of Alzheimer’s Disease in the 21st Century”. The Cyprus
Universuty of Technology School of Nursing Conference on: The Multifactorial
and Multi-level Nature of Alzheimer’s Disease
. 14 December, 2010, Nicosia,
Cyprus.
“Quality of Life, Years of Education, and Neuropsychological Performance in
Older Greek Cypriots”. 7th Panhellenic Congress on Alzheimer’s Disease and
Related Disorders, 16-20 February, 2011, Thessaloniki, Greece.
“Latest Developments in Alzheimer’s disease”. 8th Conference of the Famagusta
Medical Society ‘Galenos’, 19-20 March, 2011, Larnaca, Cyprus.
“Latest developments in the Treatment of Epilepsy”. 8th Conference of the
Famagusta Medical Society ‘Galenos’, 19-20 March, 2011, Larnaca, Cyprus.
PUBLISHED ABSTRACTS

Platform Presentations
Papacostas
SS. Walczak TS, Resor S, Scheuer, ML, Pedley TA. "Prevalence and
Risk Factors of Postictal Psychosis: A Controlled Study in an Epilepsy Monitoring
Unit", platform presentation at the scientific sessions of the American Academy of
Neurology Meetings, New York, New York, April 1993

Stylianidou G, Papacostas S, “Landau-Kleffner Syndrome: A Study of two Cases”,
Mediterranean Child Neurology Meeting, June 10-13, 1999, Crete, Greece
Panayides S, Papacostas S. “Quality of Life in Epilepsy Inventory. Greek
Translation, Validation and Development. Final Results”. Platform presentation at
the 7th European Conference on Epilepsy and Society-2000 Meeting, 19-21 May,
2000, Athens, Greece
Panayides S, Papacostas S. “Self-Reported Hierarchy of Needs: A Determinant of
Neuropsychological Assessment” Seminar on Cognitive Psychology and
Neuropsychology, co-organised by the Universities of Oslo and Cyprus, May 31st-
June 1st 2001, Nicosia, Cyprus
Covanis A, Kramer U, Aydinli N, Topku M, Papacostas S. “Epilepsy –
Comprehensive Care”. 26th Congress of the Union of Middle Eastern and
Mediterranean Paediatric Societies, Oct 4-6, 2001, Portoroz, Slovenia
Covanis A, Kramer U, Aydinli N, Topku M, Papacostas S. “Paediatric and
Adolescent Epilepsy Care in Mediterranean Countries”. 7th Mediterranean Epilepsy
Meeting, Nov 22-25, 2001, Athens, Greece
Papacostas S, Hadjivassiliou M, Xenophontos S, Cariolou M. “Correlation of Age
of Onset, ApoE Status, Family History and Education in Cypriot Patients with
Alzheimer’s Disease”. 13th Alzheimer Europe Conference, June 12-15, 2003,
Thessaloniki, Grecce
Baker GA, Jacoby A, Gorry J and the SIGN group. “Quality of Life of People with
Epilepsy: An Iran, Gulf and Near East Study”. 25th International Epilepsy
Congress, 12-16 Oct. 2003, Lisbon, Portugal
PapathanasiouE, Zamba-Papanicolaou E, Kyriakides T, Papacostas S,
Myrianthopoullou P, Pattichis C, Iliopoulos I, Piperidou C, Pantzaris M.
“Neurogenic Vestibular Evoked Potentials have a high percentage of abnormality
in patients with multiple sclerosis” 14th South-East European Society for
Neurology and Psychiatry, 16-19 Oct. 2003, Thessaliniki, Greece
Papathanasiou ES, Zamba-Papanicolaou E, Pantzaris M, Kyriakides T,
Papacostas S, Myrianthopoullou P, Pattichis C, Iliopoullos I, Piperidou T.
“Neurogenic Vestibular Potentials Using a Tone Stimulus”. 17th Annual Congress
of the Nicosia-Kyrenia Medical Society, 13-14 Sept. 2003, Nicosia, Cyprus
Papathanasiou E, Piperidou C, Iliopoulos I, Myrianthopoulou P, Pilavakis P,
Papacostas S. “Brainstem Auditory Evoked Responses That Dissapear During
Sleep: A Possible Manifestation Of A Neurogenic Vestibular Evoked Response”.
14th European Neurological Society Meeting, 26-30 June 2004, Barcelona, Spain
Papathanasiou E, Piperidou C, Iliopoulos I, Malikkidou A, Katelari-Theocharidou
E, Papacostas S. “Use of Sound Stimulation in the Evaluation of the Vestibular
System”. 19th Pancyprian Medical Congress, 24-26 September, 2004, Nicosia,
Cyprus
Papastavrou E, Kalokairinou-Anagnostopoullou A, Alevizopoulos G, Papacostas
S
, Kalakoutas Y, Sourtzi P. “Validation of the Zarit Burden Interview for the Greek
Population”. 4th Panhellenic Interdisciplinary Congress on Alzheimer’s Disease
and Related Disorders. 31st March-3rd April, 2005, Thessoliniki, Greece
Papathanasiou ES, Kyriakides T, Iliopoulos I, Petsa M, Kleopa KA, Piperidou C,
Pantzaris M, Papacostas SS. “Vestibular symptoms and signs are correlated
with abnormal neurogenic vestibular evoked potentials in patients with multiple
sclerosis”. 18th Annual Medical Conference "Hippocrates", 9-10 April, 2005,
Nicosia, Cyprus
Papathanasiou E, Loizides A, Panayiotou P, Papacostas S, Kleopa K. “Surgical
Confirmation
Electrophysiological Techniques”. 7th Greece-Cyprus Surgical Meeting, 28-30
Oct. 2005, Nicosia, Cyprus
Papastavrou E, Kalokairinou A, Alevizolpoulos G, Papacostas S, Sourtzi P.
“Stress on carers of patients with Alzheimer’s disease”. 12 Pancyprian Nursing
Conference, 25-26 Nov. 2005, Nicosia, Cyprus
Papacostas S, Papathanasiou E. “Clinical applications of vestibular evoked
potentials”. 1st Meeting of Centers-Network for Research (CeNeReN), 20 January
2006, Nicosia , Cyprus
Papathanasiou ES, Katelari-Theocharidou E, Papacostas SS. “Parallel auditory
vestibular evoked myogenic and neurogenic potential results in a case of
peripheral vestibular dysfunction, showing that the former originates from, the
vestibular system”. 19th Conference of the Nicosia-Kyrenia Medical Society
‘Hippocrates’, 4-5 November 2006, Nicosia, Cyprus
Papathanasiou ES, Myrianthopoulou P, Papacostas SS. “Pure central sleep
apnea as a side-effect of vagal nerve stimulation”. 2nd World Association of
Sleep Medicine Meeting, 4-8 February 2007, Bangkok, Thailand.
Tsangari H, Papastavrou E, Papacostas SS. “Statistics and Society: a study on
the burden experienced by caregivers of patients with Alzheimer”. Panhellenic
Congress on Statistics, 11-15 April, 2007, Nicosia, Cyprus.
E. Kkolou, A. Flourentzou, A. Malikkidou, G. Stylianidou, SS. Papacostas.
“Efficacy and tolerability of levetiracetam during one-year follow-up as add-on
therapy in patients with treatment-resistant generalised epilepsy” 17th Meeting of
the European Neurological Society, 16-20 June 2007, Rhodes, Greece
Anastasiou I, Stavrinides P, Papacostas SS. “Psychometric Properties of the
Greek Translation of the ‘Epilepsy Foundation Concerns Index’: A Pilot Study”.
3rd Pancyprian Psychiatric Meeting, 19-22 June, 2008, Limassol, Cyprus
Ryvlin P, Tomson T, On Behalf of the MORTEMUS Study (Papacostas SS,
Participant). “MORTEMUS (Mortality in Epilepsy Monitoring Unit Study):
Preliminary Findings”. 8th European Congress on Epileptology, 21-25
September, 2008, Berlin, Germany
Papastavrou E, Papacostas SS, Tsangaris H, Kalakoutas Y. “Family Caregivers
of Patients with Alzheimer's and Related Dementias: the Cyprus Experience” 5th
International Conference on Alzheimer’s Disease and Related Disorders in the
Middle East, 15-17 May, 2009, Limassol, Cyprus
Papacostas SS. “Fourteen-year mortality from Creutzfeldt-Jakob Disease in
Cyprus”. 1st International Congress on Clinical Neurology & Epidemiology, 27 - 30
August, 2009, Munich, Germany.
Constantinidou F, Stavrou M Christodoulou M, Themistocleous D, Papacostas
SS.
“The Relationship of AD8 and Cognitive Performance in Grrek Cypriot
Adults: A Preliminary Study”. 25th International Alzheimer’s Disease Congress,
10-13 March, 2010, Thessaloniki, Greece.
Papathanasiou ES, Lemesiou A, Hadjiloizou S, Myrianthopoulou P, Pantzaris M,
Papacostas SS "A New Vestibular Evoked Potential Occurring 6 msec after
Stimulus Onset with Air-Conducted Tone Auditory Stimuli". The Barany Society
Meeting, 18-21 August 2010, Reyjkavik, Iceland.

Posters
Papacostas
SS. "Oxcarbazepine versus Carbamazepine Treatment and Induction
of Liver Enzyme and Serum Lipid Level Abnormalities: Report of a Case".
International Symposium on Molecular Targets and Cellular Mechanisms of
Antiepileptic Drugs, January 1996, Genova, Italy

Papathanasiou E, Cleanthous MEG, and Papacostas SS, “Population Samples
Showing a Skewed Distribution: Is it being taken seriously?”, American Clinical
Neurophysiology Society Annual Meeting, Boston, Massachusetts, USA,
September 8-10, 1996.
Papathanasiou E, Panayiotou P, Middleton L, Stylianidou G, Koukkoulli R, and
Papacostas SS, “Ambulatory Electroencephalography is useful in differentiating
seizures from other behavioural changes”, 13th Meeting of the Union of Middle
Eastern and Mediterranean Paediatric Societies, Nicosia, Cyprus, November 9-11,
1996.
Papacostas SS, Koukkoullis R. “Lamotrigine as add-on therapy in epileptic
children with treatment-resistant epilepsy”. XVI World Congress of Neurology, Sept
14-19, 1997, Buenos Aires, Argentina.
Papacostas SS. "Photosensitivity during the Hypersomnic Phase in a Patient with
Kleine-Levin Syndrome", 9th Annual Meeting, American Neuropsychiatric
Association, Honolulu, Hawaii, Feb. 1-3, 1998
Papathanasiou E, Zamba E, Papacostas S, Middleton L, “Radial Nerve F-Waves”,
XI International Congress of EMG and Clinical Neurophysiology, Sept. 7-11, 1999,
Prague, Czech Republic
Panayides S, Papacostas S. “Quality of Life in Epilepsy Inventory-Greek
translation, Validation and Development”. 23rd International Epilepsy Congress,
Sept. 12-17, 1999, Prague, Czech Republic
Papathanasiou E, Zamba E, Papacostas S. “Normative Values for High Voltage
Stimulation across the Brachial Plexus and its use in Thoracic Outlet syndrome”.
10th European Congress of Clinical Neurophysiology, 23-26 August 2000, Lyon,
France
Hadjivassiliou M, Ayrton N, Karagrigoriou A, Papacostas S, Cariolou, M. “The
Effect of Apolipoprotein E and Presenilin-1 on Late-Onset Alzheimer’s Disease in
Cyprus” 1st International Quality Research in Dementia Conference, 19-22 Oct.
2000, London, UK
Hadjivassiliou M, Ayrton N, Karagrigoriou A, Cariolou M, Papacostas S. “The
Effect of ACE, Apolipoprotein E and Presenilin I on Late-Onset Alzheimer’s
Disease”. 2nd International Congress on Vascular Dementia, 24-27 Jan 2002,
Salzburg, Austria
Georghiou A, Tsingis M, Kyriakides T, Pantziaris M, Papacostas S, Zamba-
Papanicolaou E, Christodoulou K. “Molecular Genetic Studies of Sporadic
Spinocerebellar Ataxia (SCA) in the Cypriot Population”. 1st Mediterranean
Congress of Neurology, 25-28 Apr 2002, Limassol, Cyprus
Kappos L, Clanet M, and the European Interferon Beta-1α (AVONEX) Dose-
Comparison Study Group. “Sustained Efficacy of Interferon Beta-1α in Relapsing
Multiple Sclerosis: 4-year Results from the European Dose-Comparison Study”.
54th Annual Meeting, American Academy of Neurology, 13-20 Apr 2002, Denver,
Colorado, USA
Radue EW, Kappos L, Simonian S, Kooijmans M, Clanet M, Slasor P, Rudick RA,
the European Interferon Beta-1α Dose-Comparison Study Group. “MRI Results of
the European Interferon Beta-1α Dose-Comparison Study”. 54th Annual Meeting,
American Academy of Neurology, 13-20 Apr 2002, Denver, Colorado, USA
Papathanasiou ES, Myrianthopoulou P, Papanicolaou E, Pantziaris M, Kyriakides
T, Piperidou C, Iliopoulos I, Papacostas SS. “Click Evoked Neurogenic Vestibular
Evoked Potentials (NVESTEPs): A New Easy Method of Selectively Testing the
Vestibular Pathways of the Brainstem” Presented at the 11th European Congress of
Clinical Neurophysiology, 24-28 Aug 2002, Barcelona, Span
Kkolou E, Papacostas SS. “Levetiracetam Add-On Therapy in Patients with
Intractable Epilepsy: Initial Experience in Cyprus”. Presented at the 5th European
Congress of Epileptology, 6-10 Oct 2002, Madrid, Spain
Clanet M, Kappos L, Qunming D, Kooijman-Coutinho MF, European Interferon
Beta-1a (Avonex) Dose-Comparison Study Investigators. “Effect of Neutralizing
Antibodies (Nabs) on ths Clinical Efficacy of Interferon β-1a: Results from the
European Dose-Comparison Study”. 55th Annual Meeting, American Academy of
Neurology, 29 Mar-5 Apr 2003, Honolulu, Hawaii, USA
Papathanasiou ES, Myrianthopoulou P, Kyriakides T, Papacostas S, Iliopoullos
I, Piperidou T. “Neurogenic Vestibular Potentials Using a Tone Stimulus”. 7th
European Federation of Neurological Societies Meeting, 30 Aug-2 Sept 2003,
Helsinki, Finland
Papathanasiou E, Zamba-Papanicolaou E, Kyriakides T, Kleopa L, Pantzaris M,
Papacostas S, Iliopoulos I, Piperidou C. “Neurogenic Vestibular Evoked
Potentials in the Diagnosis of Multiple Sclerosis”. 19th Congress of the European
Committee for Treatment and Research in Multiple Sclerosis, 17-20 Sept 2003,
Milan, Italy
Papathanasiou ES, Kyriakides T, Kyriakou K, Myrianthopoulou P, Veresies K,
Papacostas S. “Video-EEG Recording of a Patient with Lafora Body Disease”.
25th International Epilepsy Congress, 12-16 Oct. 2003, Lisbon, Portugal
Kkolou E, Papacostas S. “Levetiracetam add-on therapy in patients with
intractable epilepsy”. 25th International Epilepsy Congress, 12-16 Oct. 2003,
Lisbon, Portugal
Marini C, Phillips HA, Bleasel A, Papacostas S, Vildamudi L, Sommerville L,
Neocleous V, Mulley J, Bertrand D, Berkovic SF. “Do Parasomnias and Nocturnal
Epilepsy Share the same Molecular Mechanism?” 57th Annual Meeting, American
Epilepsy Society, 5-10 Dec. 2003, Boston, USA
Kkolou E, Papacostas S. “Levetiracetam is Effective and Well-tolerated in Patients
with Intractable Epilepsy”. 6th European Congress of Epileptology, 30/5-3/6/2004,
Vienna, Austria
Papathanasiou E, Mikati M, Comair Y, Papacostas S. “Electroencephalographic
Evidence of Brain Plasticity in a Patient with Sturge-Webber Syndrome”. 6th
European Congress of Epileptology, 30/5-3/6/2004, Vienna, Austria

Kkolou E, Koukkoullis R, Dietis A, Flourentzou A, Stylianidou G, Papacostas S.
“Topiramate add-on therapy in patients with intractable epilepsy”. 14th European
Neurological Society Meeting, 26-30 June 2004, Barcelona, Spain
Papathanasiou E, Loizides A, Panayiotou P, Papacostas S, Kleopa K. “Ulnar
Neuropathy at Guyon’s Canal: Electrophysiological and Surgical Findings”. 8th
European Federation of Neurological Societies Congress, 4-7 Sept, 2004, Paris,
France
Papathanasiou E, Papacostas S, Kyriakides T, Iliopoulos I, Petsa M, Kleopa K,
Piperidou C, Pantzaris M. “Clinical correlates of abnormal neurogenic vestibular
evoked potentials in multiple sclerosis”. 20th Congress of the European
Committee for Treatment and Research in Multiple Sclerosis/ 9th Annual Meeting
of Rehabilitation in MS, 6 - 9 Oct 2004, Vienna, Austria
Kkolou E, Papacostas S, Kyriallis K, Toufexis J, Pantzaris M. “Interferon Beta-1a
(IFNβ)-1a (AVONEX) 30 µg and 60 µg Are Equaly Effective in Patients With
Relapsing Multiple Sclerosis: Results From the Cyprus Study Site of the
European IFNβ-1a Dose-Comparison Study”. 20th Congress of the European
Committee for Treatment and Research in Multiple Sclerosis, 6-9 Oct 2004,
Vienna, Austria
Papathanasiou ES, Pantzaris M, Papacostas S. “The source of far-field
neurogenic vestibular evoked responses as studied in a patient with brainstem
damage”. 12th European Congress of Clinical Neurophysiology, 8-12 May, 2005,
Stockholm, Sweden
Kkolou E, Papacostas S. “Efficacy and tolerability of levetiracetam during one-
year follow-up as add-on therapy in patients with intractable epilepsy”. 15th
Meeting of the European Neurological Society, 18 - 22 June, 2005, Vienna,
Austria
Papathanasiou ES, Papacostas SS. “Flash electroretinography using surface
electrodes and no pupil dilation, using the stimulation standards of the ISCEV”.
43rd Annual Symposium of the International Society of the Clinical
Electrophysiology of Vision (ISCEV), 23-27 August, 2005, Glasgow, Scotland
Kkolou E, Koukkoullis R, Papacostas S. “Efficacy And Tolerability Of
Lamotrigine In Children With Treatment-Resistant Epilepsy”. 26th International
Epilepsy Congress, 28 Aug – 1 Sept. 2005, Paris, France
Papastavrou E, Kalokerinou A, Kalakoutas Y, Papacostas S, Alevisopoulos G,
Sourtzi P. “Reliability and factor structure of the Zarit Burden Interview in the
Greek language”. XIII World Congress of Psychiatry, 10-15 Sept. 2005, Cairo,
Egypt
Papastavrou E, Kalokerinou A, Kalakoutas Y, Papacostas S, Alevisopoulos G,
Sourtzi P. “The burden experienced by care givers of patients with Alzheimer’s
disease”. XIII World Congress of Psychiatry, 10-15 Sept. 2005, Cairo, Egypt
Papathanasiou ES, Papacostas SS, Charalambous M, Thodi C, Pantzaris M.
“Vertigo and imbalance caused by a small lesion in the anterior insula”. 9th
European Federation of Neurological Societies Meeting, 17-20 Sept. 2005,
Athens, Greece
Zamba-Papanicolaou E, Georghiou AT, Tsingis M, Kyriakides T, Pantzaris M,
Papacostas S, Kleopa K, Christodoulou K. “Sporadic spinocerebellar ataxias
(SCA) in the Cypriot population”. 9th European Federation of Neurological
Societies Meeting, 17-20 Sept. 2005, Athens, Greece
Papathanasiou ES, Papacostas SS, Pantzaris M. “A comparison of sound-
evoked neurogenic and myogenic vestibular potentials in patients with multiple
sclerosis”. 21st Congress of the European Committee/10th Annual Meeting of the
Americas Committee for Treatment and Research in Multiple Sclerosis, 28 Sept-
1 Oct 2005, Thessaloniki, Grecce.
Papathanasiou ES, Katelari-Theocharidou, Papacostas SS. “Parallel auditory
evoked and myogenic potential results isn a case of labyrinthitis in recovery,
showing that the former examination originates from the vestibular system”. 18th
World Congress of Neurology, 5-11 November, 2005, Sydney, Australia.
Myrianthopoulou P, Dietis A, Papacostas S. “Vagus nerve stimulation therapy in
a pharmacoresistant epileptic population in Cyprus”.16th Meeting of the
European Neurological Society, 27 - 31 May 2006, Lausanne, Switzerland.
Papastavrou E, Papacostas S. “The burden experienced by caregivers with
Alzheimer’s disease and related dementias”.16th Meeting of the European
Neurological Society, 27 - 31 May 2006, Lausanne, Switzerland.
Kkolou E, Kleopa K, Papacostas S. “Efficacy and tolerability of oxcarbazepine
during one year follow-up as add-on therapy in patients with treatment-resistant
epilepsy”. 16th Meeting of the European Neurological Society, 27 - 31 May 2006,
Lausanne, Switzerland.
Christophi E, Papacostas S. “Characteristics of epileptic patients referred for
social work services” 10th European Conference on Epilepsy & Society, 2-4
August, 2006, Copenhagen, Denmark.
Myrianthopoulou P, Dietis A, Papacostas S. “Efficacy of Vagus nerve stimulation
therapy in a treatment resistant epileptic population in Cyprus”. 10th Congress of
the European Federation of Neurological Societies, 2-5 Sept 2006, Glasgow,
United Kingdom.
Papathanasiou E, Papacostas S, Pantzaris M. “Vestibular evoked neurogenic
potentials are more sensitive in detecting abnormalities than vestibular evoked
myogenic potentials in early stage multiple sclerosis”. European Committee for
Treatment and Research in Multiple Sclerosis Congress, 27-30 Sept 2006,
Madrid, Spain.

Papathanasiou ES, Thodi C, Pantzaris M, Papacostas SS. “Neurogenic potentials
using auditory stimuli originating from the vestibular system: evidence from a case
of unilateral acoustic neuroma”. 17th Meeting of the European Neurological Society,
16-20 June 2007, Rhodes, Greece
Kkolou E, Dietis A, Flourentzou A, Malikkidou A, Petsa M, Stylianidou G,
Papacostas SS. “Efficacy and tolerability of Levetiracetam during a one year
follow-up as add-on therapy in patients with treatment-resistant epilepsy”. 11th
Congress of the European Federation of Neurological Societies, 25-28 August,
2007, Brussels, Belgium

Papathanasiou ES, Lemesiou A, Myrianthopoulou P, Pantzaris M, Papacostas
SS
. “Vestibular Evoked Neurogenic Potentials Using Air-Conducted Tone
Auditory Stimuli: New Candidate Waveforms Discovered After Extensive Scalp
Mapping”. XXVth Barany Society Meeting, 31st March - April 3rd, 2008, Kyoto,
Japan
Myrianthopoulou P, Dietis A, Papacostas S. “Vagus Nerve Stimulation: an
Increasing Effectiveness”. 18th Meeting of the European Neurological Society, 7
- 11 June 2008, Nice, France
Papathanasiou ES, Lemesiou A, Myrianthopoulou P, Pantzaris M, Papacostas
SS
. “The Search for New Neurogenic Vestibular Evoked Potential Waveforms: A
Topagraphical Scalp Mapping Study Using Air-Conducted Tone Auditory Stimuli”.
18th Meeting of the European Neurological Society, 7 - 11 June 2008, Nice,
France
Constantinidou
Papacostas
“Neuropsychological Performance in Greek-Cypriot Adults with Chronic Epilepsy:
A Preliminary Study”. 8th European Congress on Epileptology, 21-25 September,
2008, Berlin, Germany
Kkolou E, Dietis A, Flourentzou A, Stylianidou G, Koukkoullis R, Papacostas S.
“Long-term efficacy and tolerability data on Topiramate as add-on therapy in
patients with treatment-resistant epilepsy”. 8th European Congress on
Epileptology, 21-25 September, 2008, Berlin, Germany
Papathanasiou ES, Papacostas SS, Myrianthopoulou P, Kkolou E, Pantzaris M,.
“Multiple Sclerosis and Epilepsy: Evidence of preferential involvement of upper limb
somatosensory evoked potentials”. 8th European Congress on Epileptology, 21-
25 September, 2008, Berlin, Germany

Constantinidou F, Themistocleous D, Nikou Maria, Papacostas S. “Effects of
Chronic Epilepsy on Neuropsychological Performance and Quality of Life in
Greek-Cypriot Adults: Preliminary findings.” American College of Rehabilitation
Medicine - American Society of Neurorehabilitation Joint Educational
Conference, 15-19 October, 2008, Toronto, Ontario, Canada
Papacostas SS, Nicou M, Themistocleous D, Constantinidou F. “Effects of
Temporal Lobe Epilepsy on Neuropsychological Performance and Quality of Life in
Greek-Cypriot adults: Preliminary Findings”. 62nd Annual Meeting of the
American Epilepsy Society, 2nd Biennial North American Regional Epilepsy
Congress, 5-9 December, 2008, Seattle, Washington, USA
Papathanasiou ES, Papacostas SS, Myrianthopoulou P, Kkolou E, Pantzaris M.
“Demyelinating Lesions Involving the Upper Limb Somatosensory Pathway may be
a Critical Factor in the Development of Epilepsy in Patients with Multiple Sclerosis”.
62nd Annual Meeting of the American Epilepsy Society, 2nd Biennial North
American Regional Epilepsy Congress, 5-9 December, 2008, Seattle,
Washington, USA
Papacostas
“Neuropsychological Performance in Adults with Chronic Epilepsy on Multi-
antiepileptic Drug Treatment”. World Psychiatric Association International
Congress, 1-4 April, 2009, Florence, Italy.
Papathanasiou ES, Papacostas SS, Myrianthopoulou P, Kkolou E, Pantzaris M.
“Demyelinating lesions involving the brainstem may be an important factor in the
development of Epilepsy in Multiple Sclerosis patients: A large retrospective
study”. 28th International Epilepsy Congress, 28th June -2nd July, Budapest,
Hungary, 2009.
Kkolou E, Dietis A, Flourentzou A, Malikkidou A, Petsa M, †Stylianidou G,
Papacostas SS. “Three-year data on efficacy and tolerability of Levetiracetam as
add-on therapy in patients with treatment-resistant epilepsy”. 28th International
Epilepsy Congress, 28th June -2nd July, Budapest, Hungary, 2009.
Myrianthopoulou P, Papathanasiou ES, Papacostas SS, Kyriakides T. “The
Contribution of Quantitative Sensory Testing in the Assessment of Symptomatic
TTRVal30Met Carriers”. 13th European Federation of Neurological Societies
Congress, 12-15 September 2009, Florence, Italy.
Papathanasiou ES, Lemesiou A, Hadjiloizou S, Myrianthopoulou P, Pantzaris M,
Papacostas SS. “A new neurogenic vestibular evoked potential (N6) recorded with
the use of air-conducted sound”. 13th European Federation of Neurological
Societies Congress, 12-15 September 2009, Florence, Italy.
Myrianthopoulou P, Papathanasiou ES, Pantzaris M, Kyriakides T, Zamba-
Papanicoloaou E, Papacostas SS. “Visual evoked potential interocular amplitude
differences matter in the end”. 19th World Congress of Neurology, 24 - 30 October,
2009, Bangkok, Thailand.
Papathanasiou ES, Papacostas SS, Myrianthopoulou P, Kkolou E, Pantzaris M.
“Demyelinating lesions involving the subthalamic nucleus may be an important
factor in the development of Epilepsy in Multiple Sclerosis patients: An evoked
potential study”. 63rd Annual Meeting of the American Epilepsy Society, 4-8
December, 2009, Boston, Massachusetts, USA.
Michaelides C, Neophytou M, Papacostas SS. “A first epidemiological study of
Psychogenic Non-Epileptic Seizures (PNES) in Cyprus”. 63rd Annual Meeting of the
American Epilepsy Society, 4-8 December, 2009, Boston, Massachusetts, USA.
Kkolou E, Dietis A, Flourentzou A, Malikkidou A, Petsa M, Stylianidou G,
Papacostas SS. “Long-term efficacy and tolerability of Levetiracetam as add-on
therapy in patients with treatment-resistant epilepsy”. 2nd East Mediterranean
Epilepsy Congress, 4-6 March, 2010, Dubai, UAE.
Papathanasiou ES, Lemesiou A, Hadliloizou S, Myrianthopoulou P, Pantzaris M,
Papacostas SS. "Vestibular Evoked Neurogenic Potentials Using Air−Conducted
Sound: The Discovery of a New Scalp Recorded Potential (N6) That Probably
Originates from the Midbrain". American Academy of Neurology 62nd Annual
Meeting, 10-17 April 17, 2010, Toronto, Ontario, Canada.
Papathanasiou ES, Lemesiou A, Hadjiloizou S, Myrianthopoulou P, Pantzaris M,
Papacostas SS. “A new scalp waveform is discovered (N6) that is vestibular in
origin after using air-conducted sound stimuli”. 20eth Meeting of the European
Neurological Society, 19-23 June, 2010, Berlin, Germany.
Votsi C, Nicolaou P, Georghiou A, Kleopa K, Middleton LT, Pantzaris M,
Papacostas S, Kyriakides T, Christodoulou K, Zamba-Papanicolaou E.
“Investigation of Sporadic Ataxia Patients in the Cypriot Population”. 14th
Congress of the European federation of Neurological Societies, 25-28
September, 2010, Geneva, Switzerland.
Papathanasiou ES, Lemesiou A, Hadjiloizou S, Myrianthopoulou P, Pantzaris M,
Papacostas SS. “A new neurogenic vestibular evoked potential (N6) recorded
with the use of air-conducted sound”. 29th International Congress of Clinical
Neurophysiology, 28th October to 2nd November, 2010, Kobe, Japan.
Papathanasiou E, Pantzaris M, Papacostas S. “Characteristics of Neurogenic
Vestibular Evoked Potentials: 700 Hz Tone Frequency Appears to Evoke the
Best Response”. 21st Meeting of the European Neurological Society, 28-31 May,
2011, Lisbon, Portugal.

Papathanasiou E, Papacostas S, Pantzaris M. “Has MRI advancement from
0.35-1.0 Tesla to 3.0 Tesla made a significant difference compared to evoked
potentials in the evaluation of patients with multiple sclerosis?” 21st Meeting of
the European Neurological Society, 28-31 May, 2011, Lisbon, Portugal.
Papathanasiou ES, Pantzaris M, Papacostas SS. “Characteristics of Neurogenic
Vestibular Evoked Potentials: Condensation Stimuli Appear to Evoke the Best
Response”. 14th European Congress on Clinical Neurophysiology, 21-25 June,
2011, Rome, Italy.

Source: http://can.ucy.ac.cy/files/SavvasPapacostasCV.pdf

avivaallen.com

Wake up and Smell the Caffeine Does the rich aroma of coffee lure you out of bed in the morning? Do you feel like you could not function without your daily caffeine fix? Drinking coffee gives you the feeling of temporary alertness and increased energy because caffeine is a stimulant that speeds up your central nervous system and is the world's most popular drug. So what's wrong with a coff

Precision refrigeration conditions of sale

1. DEFINITIONS 1.1. The ‘Seller’ means Precision Refrigeration Limited. 1.2. The ‘Buyer’ means the other party to the contract. 1.3. The contract’ means the contract between the Seller and the Buyer for the supply of the 1.4. The ‘Goods’ means the subject matter of the Contract. 1.5. Order’ means an order placed by the Buyer in accordance with Clause 2 hereof. 2. GEN

Copyright © 2010-2014 Medical Pdf Finder